The First Impact Factor of the European Journal of Therapeutics
The First Impact Factor of the European Journal of Therapeutics
复制标题
欧洲治疗学杂志第一影响因子
DOI：
10.58600/eurjther1687
复制
发表时间：
2023
影响因子：
0.3
通讯作者：
İlhan Bahsi
中科院分区：
文献类型：
--
作者：
Ayşe Balat;Ş. Eren;M. Menzilcioğlu;İlhan Bahsi
亲爱的同事们：
Journal Citation Reports 2022 年 7 月 26 日发表的声明称，期刊指标的一些重要更新将于 2023 年发布[1]。这些变化中最引人注目的是，现在将计算期刊影响因子，包括来自艺术与人文引文索引 (AHCI) 和新兴来源引文索引 (ESCI) 的期刊。
2023 年 6 月 28 日，Web of Science 索引的期刊的当前指标由 2022 年期刊引文报告共享[2]。众所周知，European Journal of Therapeutics 已被 ESCI 索引，并包含在医学、普通和内科类别中。因此，首次计算了《欧洲治疗杂志》的影响因子。
根据Journal Citation Reports最近公布的报告，《欧洲治疗杂志》2022年影响因子为0.3（图1）[3]。此外，《European Journal of Therapeutics》在医学、普通内科和 ESCI 索引期刊中的 157 种 (90/157) 期刊中排名第 90 位 [4]。
虽然《European Journal of Therapeutics》首次公布的影响因子为0.3，这并不是一个糟糕的值，但它应该更好是一个不可避免的现实。另一方面，在之前的社论中[5, 6]，有报道称《欧洲治疗杂志》接受的文章现在很快以“Accepted / Early Views Articles”的形式发表[6]。此外，据说编辑团队中还包括许多各自领域具有国际影响力的院士[5]。此外，近期还将计划对期刊的出版政策进行各种修改和改进。
我们认为，从长远来看，这些改进可能对提高《欧洲治疗学杂志》的影响因子发挥重要作用。
此致
Dear Colleagues,
The statement made by Journal Citation Reports on 26 July 2022, it was reported that some important updates in the journal metrics will be published in 2023 [1]. The most striking of these changes was that the journal impact factor would now be calculated, including journals from the Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI).
On 28 June 2023, the current metrics of the journals indexed in the Web of Science were shared by the Journal Citation Reports for 2022 [2]. As it is known, the European Journal of Therapeutics is indexed in the ESCI and is included in the Category of Medicine, General & Internal. Therefore, the impact factor was calculated for the European Journal of Therapeutics for the first time.
According to the report recently announced by Journal Citation Reports, the impact factor of the European Journal of Therapeutics for 2022 is 0.3 (Fig. 1) [3]. In addition, the European Journal of Therapeutics ranks ninetieth among one hundred fifty-seven (90/157) in the Category of Medicine, General & Internal, and ESCI-indexed journals [4].
Although the first impact factor declared for the European Journal of Therapeutics is 0.3 is not a bad value, it is an inevitable reality that it should be better. On the other hand, in previous editorials [5, 6], it was reported that the articles accepted in the European Journal of Therapeutics were now published as Accepted / Early Views Articles quickly [6]. In addition, it was stated that the editorial team was enriched with many internationally important academicians in their fields [5]. Moreover, there will be various revisions and improvements planned to be made to the journal's publication policy in the near future.
We think these improvements may play an essential role in increasing the impact factor of the European Journal of Therapeutics in the long term.
Yours sincerely